BioNTech SE (BNTX) Reports Q4 EPS of EUR1.08; offers guidance

BioNTech SE (NASDAQ: BNTX) reported Q4 EPS of EUR1.08. Revenue for the quarter came in at EUR1.19 billion versus the consensus estimate of EUR1.12 billion.

GUIDANCE:

BioNTech SE sees FY2025 revenue of EUR1.7-2.2 billion.

For earnings history and earnings-related data on BioNTech SE (BNTX) click here.

You May Also Be Interested In

• Concurrent Technologies (CNC:LN) PT Raised to GBP3.20 at Berenberg
• UBS Starts Internet Initiative Japan Inc (3774:JP) (IIJIY) at Neutral
• Bernstein SocGen Group Reiterates Outperform Rating on Zydus Lifesciences (ZYDUSLIF:IN)